{"title":"对有关 \"轻度至中度α-甘露糖苷酶病患者接受 velmanase alfa 与骨髓移植或无因果关系疗法的成本效益对比 \"的致编辑函的回复","authors":"Ivana Stević, Slobodan M. Janković","doi":"10.1080/13102818.2024.2386488","DOIUrl":null,"url":null,"abstract":"Published in Biotechnology & Biotechnological Equipment (Vol. 38, No. 1, 2024)","PeriodicalId":9076,"journal":{"name":"Biotechnology & Biotechnological Equipment","volume":"47 1","pages":""},"PeriodicalIF":1.5000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Response to the Letter to the Editor concerning ‘Cost-effectiveness of velmanase alfa vs. bone marrow transplantation or no causal therapy in patients with mild to moderate alpha-mannosidosis’\",\"authors\":\"Ivana Stević, Slobodan M. Janković\",\"doi\":\"10.1080/13102818.2024.2386488\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Published in Biotechnology & Biotechnological Equipment (Vol. 38, No. 1, 2024)\",\"PeriodicalId\":9076,\"journal\":{\"name\":\"Biotechnology & Biotechnological Equipment\",\"volume\":\"47 1\",\"pages\":\"\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2024-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biotechnology & Biotechnological Equipment\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.1080/13102818.2024.2386488\",\"RegionNum\":4,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotechnology & Biotechnological Equipment","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1080/13102818.2024.2386488","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
Response to the Letter to the Editor concerning ‘Cost-effectiveness of velmanase alfa vs. bone marrow transplantation or no causal therapy in patients with mild to moderate alpha-mannosidosis’
Published in Biotechnology & Biotechnological Equipment (Vol. 38, No. 1, 2024)
期刊介绍：
Biotechnology & Biotechnological Equipment (B&BE) is an international open access journal publishing cutting-edge research. A modern world requires modern biotechnology and nanobiology. The journal is a forum that provides society with valuable information for a healthy and better life and promotes “the Science and Culture of Nature”.
The journal publishes original research and reviews with a multidisciplinary perspective; expanded case reports with a focus on molecular medical research and advanced practice in evidence-based medicine are also considered.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
